SEC Form D · filed January 6, 2023
Outlook Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Faisal G. Sukhtian · Iselin, NJDirectorRandy H. Thurman · Iselin, NJDirectorKurt J. Hilzinger · Iselin, NJDirectorLawrence A. Kenyon · Iselin, NJExec · DirectorAndong G. Huang · Iselin, NJDirectorJulian G. Gangolli · Iselin, NJDirectorC. R. Trenary · Iselin, NJExec · DirectorYezan H. Haddadin · Iselin, NJDirectorGerd G. Auffarth · Iselin, NJDirectorJulia A. Haller · Iselin, NJDirectorMark H. Barineau · Houston, TXDirectorJoseph J. Gault · Greenwich, CTDirectorJames Bracken · Schaumburg, ILDirectorLuke Terrell · Fayetteville, ARDirectorMichael A. Barr · Greenwich, CTDirectorMelvyn Reznick · Reno, NVExec · DirectorGilles Lamarre · Ottawa, Ontario, CanadaExec · DirectorRajesh Sharma · Saint-Laurent, Quebec, CanadaDirectorM. W. Macey, Jr · Greenwich, CTDirectorAlan Pierrot · Fresno, CADirectorAvraham D. Dreyfuss · New York, NYDirectorMichael A. Scott · San Francisco, CADirectorAubrey Rankin · AUSTIN, TXDirectorDon Maniccia · AUSTIN, TXDirectorJared Hoffman · New York, NYDirectorNikolaos Perros · New York, NYDirectorLu Cai · New York, NYExec · DirectorXiao Jian Wang · New York, NYDirectorYun Zhang · New York, NYExec · DirectorLei Zhang · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗